Convergence Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Sell
5,074
-451
-8% -$105K 0.13% 86
2025
Q4
$1.14M Sell
5,525
-199
-3% -$39.4K 0.17% 73
2025
Q3
$1.06M Sell
5,724
-608
-10% -$104K 0.16% 79
2025
Q2
$967K Buy
6,332
+132
+2% +$20.3K 0.17% 77
2025
Q1
$1.03M Buy
6,200
+1,099
+22% +$172K 0.2% 66
2024
Q4
$738K Sell
5,101
-344
-6% -$53.3K 0.15% 71
2024
Q3
$882K Sell
5,445
-1,664
-23% -$265K 0.19% 66
2024
Q2
$1.04M Buy
+7,109
New +$1.06M 0.27% 53

Other funds holding JNJ

Convergence Financial's JNJ Position: Q1 2026 in Review

Convergence Financial reduced its Johnson & Johnson (JNJ) stake by 8.2% in Q1 2026, selling an estimated $105K and leaving 5,074 shares worth $1.24M. The position accounts for 0.13% of the portfolio, ranked #86.

Convergence Financial first reported a position in JNJ in Q2 2024 and has held it in 8 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Convergence Financial held 5,074 shares of Johnson & Johnson worth $1.24M as of Q1 2026.
  • Convergence Financial sold 451 Johnson & Johnson shares in Q1 2026, an estimated $105K.
  • Johnson & Johnson made up 0.13% of Convergence Financial's portfolio in Q1 2026, its #86 holding.
  • Convergence Financial first reported a position in Johnson & Johnson in Q2 2024 and has held it in 8 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Convergence Financial's 13F filing for Q1 2026, filed 11 May 2026.